2023-08-012024-07-312024-07-31false09116741HEALTHBRIDGE DIRECT LIMITED2025-02-26falseiso4217:GBPxbrli:pure091167412023-08-01091167412024-07-31091167412023-08-012024-07-31091167412022-08-01091167412023-07-31091167412022-08-012023-07-3109116741bus:SmallEntities2023-08-012024-07-3109116741bus:AuditExempt-NoAccountantsReport2023-08-012024-07-3109116741bus:FullAccounts2023-08-012024-07-3109116741bus:PrivateLimitedCompanyLtd2023-08-012024-07-3109116741core:WithinOneYear2024-07-3109116741core:AfterOneYear2024-07-3109116741core:WithinOneYear2023-07-3109116741core:AfterOneYear2023-07-3109116741core:ShareCapital2024-07-3109116741core:SharePremium2024-07-3109116741core:RevaluationReserve2024-07-3109116741core:OtherReservesSubtotal2024-07-3109116741core:RetainedEarningsAccumulatedLosses2024-07-3109116741core:ShareCapital2023-07-3109116741core:SharePremium2023-07-3109116741core:RevaluationReserve2023-07-3109116741core:OtherReservesSubtotal2023-07-3109116741core:RetainedEarningsAccumulatedLosses2023-07-3109116741core:LandBuildings2024-07-3109116741core:PlantMachinery2024-07-3109116741core:Vehicles2024-07-3109116741core:FurnitureFittings2024-07-3109116741core:OfficeEquipment2024-07-3109116741core:NetGoodwill2024-07-3109116741core:IntangibleAssetsOtherThanGoodwill2024-07-3109116741core:ListedExchangeTraded2024-07-3109116741core:UnlistedNon-exchangeTraded2024-07-3109116741core:LandBuildings2023-07-3109116741core:PlantMachinery2023-07-3109116741core:Vehicles2023-07-3109116741core:FurnitureFittings2023-07-3109116741core:OfficeEquipment2023-07-3109116741core:NetGoodwill2023-07-3109116741core:IntangibleAssetsOtherThanGoodwill2023-07-3109116741core:ListedExchangeTraded2023-07-3109116741core:UnlistedNon-exchangeTraded2023-07-3109116741core:LandBuildings2023-08-012024-07-3109116741core:PlantMachinery2023-08-012024-07-3109116741core:Vehicles2023-08-012024-07-3109116741core:FurnitureFittings2023-08-012024-07-3109116741core:OfficeEquipment2023-08-012024-07-3109116741core:NetGoodwill2023-08-012024-07-3109116741core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3109116741core:ListedExchangeTraded2023-08-012024-07-3109116741core:UnlistedNon-exchangeTraded2023-08-012024-07-3109116741core:MoreThanFiveYears2023-08-012024-07-3109116741core:Non-currentFinancialInstruments2024-07-3109116741core:Non-currentFinancialInstruments2023-07-3109116741dpl:CostSales2023-08-012024-07-3109116741dpl:DistributionCosts2023-08-012024-07-3109116741core:LandBuildings2023-08-012024-07-3109116741core:PlantMachinery2023-08-012024-07-3109116741core:Vehicles2023-08-012024-07-3109116741core:FurnitureFittings2023-08-012024-07-3109116741core:OfficeEquipment2023-08-012024-07-3109116741dpl:AdministrativeExpenses2023-08-012024-07-3109116741core:NetGoodwill2023-08-012024-07-3109116741core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3109116741dpl:GroupUndertakings2023-08-012024-07-3109116741dpl:ParticipatingInterests2023-08-012024-07-3109116741dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-012024-07-3109116741core:ListedExchangeTraded2023-08-012024-07-3109116741dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-012024-07-3109116741core:UnlistedNon-exchangeTraded2023-08-012024-07-3109116741dpl:CostSales2022-08-012023-07-3109116741dpl:DistributionCosts2022-08-012023-07-3109116741core:LandBuildings2022-08-012023-07-3109116741core:PlantMachinery2022-08-012023-07-3109116741core:Vehicles2022-08-012023-07-3109116741core:FurnitureFittings2022-08-012023-07-3109116741core:OfficeEquipment2022-08-012023-07-3109116741dpl:AdministrativeExpenses2022-08-012023-07-3109116741core:NetGoodwill2022-08-012023-07-3109116741core:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3109116741dpl:GroupUndertakings2022-08-012023-07-3109116741dpl:ParticipatingInterests2022-08-012023-07-3109116741dpl:GroupUndertakingscore:ListedExchangeTraded2022-08-012023-07-3109116741core:ListedExchangeTraded2022-08-012023-07-3109116741dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-08-012023-07-3109116741core:UnlistedNon-exchangeTraded2022-08-012023-07-3109116741core:NetGoodwill2024-07-3109116741core:IntangibleAssetsOtherThanGoodwill2024-07-3109116741core:LandBuildings2024-07-3109116741core:PlantMachinery2024-07-3109116741core:Vehicles2024-07-3109116741core:FurnitureFittings2024-07-3109116741core:OfficeEquipment2024-07-3109116741core:AfterOneYear2024-07-3109116741core:WithinOneYear2024-07-3109116741core:ListedExchangeTraded2024-07-3109116741core:UnlistedNon-exchangeTraded2024-07-3109116741core:ShareCapital2024-07-3109116741core:SharePremium2024-07-3109116741core:RevaluationReserve2024-07-3109116741core:OtherReservesSubtotal2024-07-3109116741core:RetainedEarningsAccumulatedLosses2024-07-3109116741core:NetGoodwill2023-07-3109116741core:IntangibleAssetsOtherThanGoodwill2023-07-3109116741core:LandBuildings2023-07-3109116741core:PlantMachinery2023-07-3109116741core:Vehicles2023-07-3109116741core:FurnitureFittings2023-07-3109116741core:OfficeEquipment2023-07-3109116741core:AfterOneYear2023-07-3109116741core:WithinOneYear2023-07-3109116741core:ListedExchangeTraded2023-07-3109116741core:UnlistedNon-exchangeTraded2023-07-3109116741core:ShareCapital2023-07-3109116741core:SharePremium2023-07-3109116741core:RevaluationReserve2023-07-3109116741core:OtherReservesSubtotal2023-07-3109116741core:RetainedEarningsAccumulatedLosses2023-07-3109116741core:NetGoodwill2022-08-0109116741core:IntangibleAssetsOtherThanGoodwill2022-08-0109116741core:LandBuildings2022-08-0109116741core:PlantMachinery2022-08-0109116741core:Vehicles2022-08-0109116741core:FurnitureFittings2022-08-0109116741core:OfficeEquipment2022-08-0109116741core:AfterOneYear2022-08-0109116741core:WithinOneYear2022-08-0109116741core:ListedExchangeTraded2022-08-0109116741core:UnlistedNon-exchangeTraded2022-08-0109116741core:ShareCapital2022-08-0109116741core:SharePremium2022-08-0109116741core:RevaluationReserve2022-08-0109116741core:OtherReservesSubtotal2022-08-0109116741core:RetainedEarningsAccumulatedLosses2022-08-0109116741core:AfterOneYear2023-08-012024-07-3109116741core:WithinOneYear2023-08-012024-07-3109116741core:Non-currentFinancialInstrumentscore:CostValuation2023-08-012024-07-3109116741core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-012024-07-3109116741core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-012024-07-3109116741core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-012024-07-3109116741core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-012024-07-3109116741core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-012024-07-3109116741core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3109116741core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3109116741core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3109116741core:Non-currentFinancialInstrumentscore:CostValuation2024-07-3109116741core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-3109116741core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-3109116741core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-3109116741core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-3109116741core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-3109116741core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-3109116741core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-3109116741core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-3109116741core:Non-currentFinancialInstrumentscore:CostValuation2023-07-3109116741core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-3109116741core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-3109116741core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-3109116741core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-3109116741core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-3109116741core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-3109116741core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-3109116741core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-3109116741bus:Director12023-08-012024-07-3109116741bus:Director22023-08-012024-07-3109116741bus:Director32023-08-012024-07-3109116741bus:Director42023-08-012024-07-3109116741bus:Director52023-08-012024-07-3109116741bus:Director62023-08-012024-07-31

HEALTHBRIDGE DIRECT LIMITED

Registered Number
09116741
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2024

HEALTHBRIDGE DIRECT LIMITED
Company Information
for the year from 1 August 2023 to 31 July 2024

Directors

ALI, Shabnam Noureen, Dr
BHATTI, Humaira Rizwan, Dr
ILES, Susan, Dr
PAZHANISAMI, Sangeetha, Dr
RAMAKRISHNAN, Sivashanmugarajan, Dr
TAHIR, Muhammad, Dr

Registered Address

The Vintry
Redbridge Lane East
Ilford
IG4 5EY

Registered Number

09116741 (England and Wales)
HEALTHBRIDGE DIRECT LIMITED
Balance Sheet as at
31 July 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets36523,784
6523,784
Current assets
Debtors42,222,185864,087
Cash at bank and on hand2,730,4894,179,963
4,952,6745,044,050
Creditors amounts falling due within one year5(4,334,026)(4,456,699)
Net current assets (liabilities)618,648587,351
Total assets less current liabilities619,300591,135
Provisions for liabilities6(305)(305)
Net assets618,995590,830
Capital and reserves
Profit and loss account618,995590,830
Shareholders' funds618,995590,830
The financial statements were approved and authorised for issue by the Board of Directors on 26 February 2025, and are signed on its behalf by:
RAMAKRISHNAN, Sivashanmugarajan, Dr
Director
Registered Company No. 09116741
HEALTHBRIDGE DIRECT LIMITED
Notes to the Financial Statements
for the year ended 31 July 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is The Vintry, Redbridge Lane East, Ilford, IG4 5EY.
Statement of compliance
These individual financial statements have been prepared in accordance with FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A and Companies Act 2006, as applicable to companies subject to the small companies' regime.
Basis of preparation
The financial statements have been prepared on the historical cost basis and in accordance with the Companies Act 2006.The presentation and functional currency of the company is pounds sterling. The financial statements are presented in pound units (£) unless stated otherwise.
Revenue from sale of goods
Sales of goods are recognised when the company has delivered the goods to the customer, no other significant obligation remains unfulfilled that may affect the customer's acceptance of the products and risks and rewards of ownership have transferred to them.
Revenue from rendering of services
Revenue from provision of services rendered in the reporting period is recognised when the outcome of a transaction for the rendering of services can be estimated reliably in terms of revenue, costs and its stage of completion of the specific transaction at the end of the reporting period. The stage of completion is determined on the basis of the actual completion of a proportion of the total services to be rendered. When the outcome of a service contract cannot be estimated reliably the company only recognises revenue to the extent of the recoverable expenses recognised.
Tangible fixed assets and depreciation
Property, plant and equipment is stated at cost less accumulated depreciation and impairment losses. Part of an item of property, plant and equipment having different useful lives are accounted for as separate items. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives, using the straight­line method. The estimated useful lives, residual values and depreciation method are reviewed at the end of each reporting period, with the effect of any changes in estimate accounted for on a prospective basis. Depreciation is provided to write off the cost less estimated residual value, of each asset over its expected useful life as follows: Asset class and depreciation rate Equipment 33% straight line
2.Average number of employees

20242023
Average number of employees during the year146114
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 August 2354,64654,646
At 31 July 2454,64654,646
Depreciation and impairment
At 01 August 2350,86250,862
Charge for year3,1323,132
At 31 July 2453,99453,994
Net book value
At 31 July 24652652
At 31 July 233,7843,784
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables2,142,62489,380
Prepayments and accrued income79,561774,707
Total2,222,185864,087
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables22,294175,209
Taxation and social security30,134101,061
Accrued liabilities and deferred income4,281,5984,180,429
Total4,334,0264,456,699
6.Provisions for liabilities

2024

2023

££
Other provisions305305
Total305305